A virtual pharmacy visit may ease opioid fears for cancer patients

NCT ID NCT07737314

First seen Jul 30, 2026 · Last updated Jul 31, 2026 · Updated 1 time

Summary

This pilot study tests whether a group telehealth session led by a palliative care pharmacist can help cancer patients better understand and manage their opioid pain medications. Many patients struggle with side effects, complex dosing, and fear of addiction, which can lead to undertreated pain. Participants attend one online education session and complete surveys before and after to measure changes in opioid knowledge and confidence. The goal is to see if this approach is practical and well-received enough to expand.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a telehealth pharmacist-led group opioid education session
What this could lead to
If successful, this telehealth education model could be a scalable way to help cancer patients manage opioid pain relief more safely and confidently.
What could go wrong
This is a small pilot study with only 50 participants, so results may not apply broadly. The study measures feasibility and acceptability, not direct health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMATOPOIETIC AND LYMPHATIC SYSTEM NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Fred Hutch/University of Washington Cancer Consortium

    Seattle, Washington, 98109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.